Literature DB >> 9105653

Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan.

M Mizuguchi1.   

Abstract

The clinical, radiological and pathological features of acute necrotizing encephalopathy of childhood, a disease entity established recently, are described. This disease predominantly affects infants and young children living in Japan and Taiwan, and manifests itself as acute encephalopathy following viral infections. The hallmark of this encephalopathy is multifocal, symmetric brain lesions affecting the bilateral thalamus, brainstem tegmentum, cerebral periventricular white matter and cerebellar medulla, which can be visualized by computed tomography and magnetic resonance imaging. Both the gray and white matter are involved, with neuropathological evidence of local breakdown of the blood-brain barrier (dysoria). The prognosis was poor in the 1980s, but has improved recently. A characteristic combination of focal neurologic signs is often recognized as the sequelae. Its distinction from clinically similar conditions, such as the Reye syndrome, and from pathologically related conditions, such as the Leigh and Wernicke encephalopathies, is also discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9105653     DOI: 10.1016/s0387-7604(96)00063-0

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  71 in total

1.  Acute necrotizing encephalopathy secondary to diphtheria, tetanus toxoid and whole-cell pertussis vaccination: diffusion-weighted imaging and proton MR spectroscopy findings.

Authors:  Hale Aydin; Esra Ozgul; Ahmet Muhtesem Agildere
Journal:  Pediatr Radiol       Date:  2010-01-30

2.  Clinical and radiological features of rotavirus cerebellitis.

Authors:  J Takanashi; T Miyamoto; N Ando; T Kubota; M Oka; Z Kato; S Hamano; S Hirabayashi; M Kikuchi; A J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-27       Impact factor: 3.825

3.  Brain magnetic resonance imaging of an adult case of acute necrotizing encephalopathy.

Authors:  Haruhisa Kato; Hideo Hasegawa; Mutsumi Iijima; Masanobu Uchigata; Taizo Terada; Yasusei Okada
Journal:  J Neurol       Date:  2007-02-08       Impact factor: 4.849

Review 4.  Untreated recurrent acute necrotising encephalopathy associated with RANBP2 mutation, and normal outcome in a Caucasian boy.

Authors:  Ne-Ron Loh; Donald Barry Appleton
Journal:  Eur J Pediatr       Date:  2010-05-15       Impact factor: 3.183

5.  Acute necrotizing encephalopathy: combined therapy and favorable outcome in a new case.

Authors:  Renzo Manara; Malida Franzoi; Paola Cogo; Pier Antonio Battistella
Journal:  Childs Nerv Syst       Date:  2006-03-14       Impact factor: 1.475

6.  Acute necrotising encephalopathy in a child with H1N1 influenza infection: a clinicoradiological diagnosis and follow-up.

Authors:  Sangeetha Yoganathan; Sniya Valsa Sudhakar; Ebor Jacob James; Maya Mary Thomas
Journal:  BMJ Case Rep       Date:  2016-01-11

7.  Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.

Authors:  Katharina Wolf; Thomas Schmitt-Mechelke; Spyridon Kollias; Armin Curt
Journal:  J Neurol       Date:  2013-01-18       Impact factor: 4.849

8.  Acute necrotizing encephalopathy: diffusion MR imaging and localized proton MR spectroscopic findings in two infants.

Authors:  Hyun Woo Goo; Choong-Gon Choi; Chong Hyun Yoon; Tae-Sung Ko
Journal:  Korean J Radiol       Date:  2003 Jan-Mar       Impact factor: 3.500

9.  Clinical spectrum and prognostic factors of acute necrotizing encephalopathy in children.

Authors:  Hye-Eun Seo; Su-Kyeong Hwang; Byung Ho Choe; Min-Hyun Cho; Sung-Pa Park; Soonhak Kwon
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

10.  Specific HLA genotypes confer susceptibility to acute necrotizing encephalopathy.

Authors:  A Hoshino; M Saitoh; T Miyagawa; M Kubota; J-I Takanashi; A Miyamoto; K Tokunaga; A Oka; M Mizuguchi
Journal:  Genes Immun       Date:  2016-07-28       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.